Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results

Journal of Urology

Volumn 164, Issue 3 I, 2000, Pages 692-697

  Schurch, B ^a   Stohrer M ^b   Kramer, G ^b   Schmid, D M ^b   Gaul, G ^b   Hauri, D ^b  

^a BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

^b NONE

Author keywords

Bladder; Botulinum toxin type A; Neurogenic; Spinal cord injuries; Urinary incontinence

Indexed keywords

BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ADOLESCENT; ADULT; ARTICLE; BLADDER CAPACITY; BLADDER CATHETERIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; DETRUSOR DYSSYNERGIA; DOSE RESPONSE; DRUG RESISTANCE; FEMALE; HUMAN; HYPERREFLEXIA; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; SPINAL CORD INJURY; TREATMENT OUTCOME; URGE INCONTINENCE;

EID: 0033870343     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)67283-7     Document Type: Article

References (40)

1. Abrams, P., Larsson, G., Chapple, C. et al: Factors involved in the success of antimuscarinic treatment. BJU Int, suppl., 83: 42, 1999
2. Brindley, G. S.: The first 500 patients with sacral anterior root stimulator implants: general description. Paraplegia, 32: 795, 1994
3. Ewing, R., Bultitude, M. I., Shuttleworth, K E. et al: Subtrigonal phenol injection for urge incontinence secondary to detrusor instability in females. Br J Urol, 54: 689, 1982
4. Maggi, C. A.: Therapeutic potential of capsaicin-like molecules: studies in animals and humans. Life Sci, 51: 1777, 1992
5. Fowler, C. J., Beck, R. O., Gerrard, S. et al: Intravesical capsaicin for treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry, 57: 169, 1994
6. Chandiramani, V. A., Peterson, T., Duthie, G. S. et al.: Urodynamic changes during intravesical instillations of capsaicin. Br J Urol, 77: 792, 1996
7. De Ridder, D., Chandramani, V., Dasgupta, P. et al: Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup. J Urol, 158:2087, 1997
8. de Sèze, M., Wiart, L., Joseph, P. A. et al: Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn, 17: 513, 1998
9. Chancellor, M. B.: Should we be using chili-pepper extracts to treat the overactive bladder? J Urol, 158: 2097, 1997
10. Craft, R., Carlisi, V. J., Mattia, A. et al: Behavioural characterization of the excitatory and desensitizing effects of intravesical capsaicin and resiniferatoxin in the rat. Pain, 55: 205, 1993
11. Szolcsanyi, J., Szallasi, A., Szallasi, Z. et al: Resiniferatoxin: an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons. Pharmacol Exp Ther, 255: 923, 1990
12. Lazzeri, M., Beneforti, P. and Turini, D.: Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor. J Urol, 158: 2093, 1997
13. Chancellor, M. B. and de Groat, W. C.: Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the over-active bladder. J Urol, 162: 3, 1999
14. Plevnik, S. and Janez, J.: Maximal electrical stimulation for urinary incontinence: report of 98 cases. Urology, 14: 638, 1979
15. Schmidt, R. A.: Applications of neurostimulation in urology. Neurourol Urodyn, 7: 585, 1988
16. Madersbacher, H., Wyndaele, J. J., Igawa, Y. et al: Conservative management in the neuropathic patient. In: Incontinence. Edited by P. Abrams, S. Khoury and A. Wein. Plymouth: Plymbridge Distributors, Ltd., chapt. 19, pp. 777-812, 1999
17. Pasricha, P. J, Rai, R., Ravich, W. J. et al: Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology, 110: 1410, 1996
18. Annese, V., Basciani, M., Borrelli, O. et al: Intrasphincteric injection of botulinum toxin is effective in long-term treatment of esophageal achalasia. Muscle Nerve, 21: 1540, 1998
19. Naumann, M., Flachenecker, P., Bröcker, E. B. et al: Botulinum toxin for palmar hyperhidrosis. Lancet, 349: 252, 1997
20. Naumann, M., Zellner, M., Toyka, K. V. et al: Treatment of gustatory sweating with botulinum toxin. Ann Neurol, 42: 973, 1997
21. Blaivas, J. G., Awad, S. A., Bissana, N. et al: Urodynamic procedures: recommendations of the Urodynamics Society. I. Procedures that should be available for routine urologic practice. Neurourol Urodyn, 1: 51, 1982
22. Bates, P., Bradley, W. E., Glen, E. et al: The standardization of terminology of lower urinary tract function. J Urol, 121: 551, 1979
23. Scott, A. B.: Botulinum toxin treatment of eye muscles to correct strabismus. Trans Am Ophthalmol Soc 79: 734, 1981
24. Clinical use of botulinum toxin. National Institutes of Health Consensus Development Conference Statement, Nov 12-14, 1990. Arch Neurol, 48: 1294, 1991
25. Borodic, G. E. and Cozzolino, D.: Blepharospasm and its treatment, with emphasis on the use of botulinum toxin. Plast Reconstr Surg, 83: 546, 1989
26. Jankovic, J. and Schwartz, K S.: Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology, 43: 834, 1993
27. Pierson, S. H., Katz, D. I. and Tarsy, D.: Botulinum toxin A in the treatment of spasticity: functional implications and patient selection. Arch Phys Med Rehabil, 77: 717, 1996
28. Dolly, J. O., de Paiva, A., Foran, P. et al: Probing the process of transmitter release with botulinum and tetanus neurotoxins. Semin Neurosci, 6: 149, 1994
29. Simpson, L. L.: The neuroparalytic and hemagglutining activities of botulinum toxin: In: Neuropoisons: Their Pathophysiological Actions. New York: Plenum Press, vol. 1, chapt. 14, pp. 303-324, 1971
30. Drachman, D. B.: Botulinum toxin as a tool for research on the nervous system. In: Neuropoisons: Their Pathophysiological Actions. Edited by L. L. Simpson. New York: Plenum Press, vol. 1, chapt. 15, pp. 325-347, 1971
31. Fex, S., Sonesson, B., Thesleff, S. et al: Nerve implants in botulinum poisoned mammalian muscle. J Physiol (Lond), 184: 872, 1966
32. Dickson, E. C. and Shevky, R.: Studies on the manner in which the toxin of clostridium botulinum acts upon the body. I. The effect upon the autonomic nervous system. J Exp Med , 37: 711, 1923
33. Carpenter, F. G.: Motor responses of the urinary bladder and skeletal muscle in botulinum intoxicated rats. J Physiol, 188: 1, 1967
34. Dixon, J. and Glosing, J.: Structure and innervation in the human. In: The Physiology of the Lower Urinary Tract. Edited by M. Torrens and J. F. B. Morrison. New York: Springer-Verlag, chapt. 1, pp. 3-22, 1987
35. Brading, A.: Physiology of bladder smooth muscle. In: The Physiology of the Lower Urinary tract. Edited by M. Torrens and J. F. B. Morrison. New York: Springer-Verlag, chapt. 6, pp. 161-192, 1987
36. Schurch, B., Hauri, D., Rodic, B. et al: Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol, 155: 1023, 1996
37. Molgo, J., Comella, J. X., Angaut-Petit, D. et al: Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions. J Physiol (Paris), 84: 152, 1990
38. Holds, J. B., Alderson, K, Fogg, S. G. et al: Motor nerve sprouting in human orbicularis muscle after botulinum A injection. Invest Ophthalmol Vis Sci, 31: 964, 1990
39. Paul, M. L. and Cook, M. A.: Lack of effect of botulinum toxin on nonadrenergic, noncholinergic inhibitory responses of the guinea pig fundus in vitro. Can J Physiol Pharmacol, 58: 88, 1980
40. Bors, E., Rossier, A. and Sullivan, F. J.: Urological and neurological observations following anesthetic procedures for bladder rehabilitation of patients with spinal cord injuries. Cystometric and electromyographic effects of topical anesthesias. Urol Surv, 12: 205, 1962